Albuminuria and Estimated GFR 5 Years After Escherichia coli O157 Hemolytic Uremic Syndrome: An Update

American Journal of Kidney Diseases

Volumn 51, Issue 3, 2008, Pages 435-444

  Garg, Amit X ^a   Salvadori, Marina ^a   Okell, Justin M ^a   Thiessen Philbrook, Heather R ^a   Suri, Rita S ^a   Filler, Guido ^a   Moist, Louise ^a   Matsell, Douglas ^b   Clark, William F ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

chronic kidney disease; Cohort study; diabetes; Escherichia coli O157; hemolytic uremic syndrome; hypertension; proteinuria

Indexed keywords

ALBUMIN; CREATININE; CYSTATIN C;

ADOLESCENT; ALBUMINURIA; ARTICLE; CHILD; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; ESCHERICHIA COLI K 12; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPERTENSION; MALE; OUTCOME ASSESSMENT; PROGNOSIS;

ALBUMINURIA; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; ESCHERICHIA COLI O157; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; INFANT; KIDNEY FUNCTION TESTS; MALE; ONTARIO; PROGNOSIS; PROSPECTIVE STUDIES; WATER MICROBIOLOGY; WATER SUPPLY;

EID: 39449120049     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2007.10.042     Document Type: Article

References (44)

1. Martin D.L., MacDonald K.L., White K.E., Soler J.T., and Osterholm M.T. The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota. N Engl J Med 323 (1990) 1161-1167
2. Karmali M.A., Petric M., Lim C., Fleming P.C., Arbus G.S., and Lior H. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. 1985. J Infect Dis 189 (2004) 556-563
3. Garg A.X., Suri R.S., Barrowman N., et al. Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: A systematic review, meta-analysis, and meta-regression. JAMA 290 (2003) 1360-1370
4. Ogborn M.R., Hamiwka L., Orrbine E., et al. Renal function in Inuit survivors of epidemic hemolytic-uremic syndrome. Pediatr Nephrol 12 (1998) 485-488
5. McLean M.M., Jones C.H., and Sutherland D.A. Haemolytic-uraemic syndrome. A report of an outbreak. Arch Dis Child 41 (1966) 76-81
6. Vermylen C., Bodart E., Ninane J., Moulin D., and Cornu G. The haemolytic uraemic syndrome of childhood: Is living in Belgium a factor of good prognosis?. Acta Clin Belg 43 (1988) 101-108
7. Brichard B., Vermylen C., Heremans M.T., Ninane J., and Cornu G. Plasma infusion as treatment for 33 children with haemolytic uraemic syndrome: A good therapy?. Acta Clin Belg 48 (1993) 156-163
8. Miyazaki S. The etiology and clinical features of hemolytic uremic syndrome. Rinsho Ketsueki 35 (1994) 341-345
9. Riella M.C., George C.R., Hickman R.O., et al. Renal microangiopathy of the hemolytic-uremic syndrome in childhood. Nephron 17 (1976) 188-203
10. Guyot C., Daniel M.D., Roze J.C., Renoult E., Dubigeon P., and Buzelin F. Prognosis of hemolytic uremic syndrome in children. Importance of extrarenal involvement. Arch Fr Pediatr 43 (1986) 253-258
11. Rizzoni G., Claris-Appiani A., Edefonti A., et al. Plasma infusion for hemolytic-uremic syndrome in children: Results of a multicenter controlled trial. J Pediatr 112 (1988) 284-290
12. Brandt J.R., Joseph M.W., Fouser L.S., et al. Cholelithiasis following Escherichia coli O157:H7-associated hemolytic uremic syndrome. Pediatr Nephrol 12 (1998) 222-225
13. Sorrenti L.Y., and Lewy P.R. The hemolytic-uremic syndrome: Experience at a center in the Midwest. Am J Dis Child 132 (1978) 59-62
14. Campos A., Kim Y., Miller K., Mauer S.M., Loken M.K., and Michael A.F. Radionuclide studies of the kidney in children with hemolytic-uremic syndrome. Radiology 145 (1982) 811-813
15. Diekmann L. Treatment of the hemolytic-uremic syndrome with streptokinase and heparin (author's translation). Klin Padiatr 192 (1980) 430-435
16. Loirat C., Beaufils F., Sonsino E., et al. Treatment of childhood hemolytic-uremic syndrome with urokinase. Cooperative controlled trial. Arch Fr Pediatr 41 (1984) 15-19
17. Henning P.H., Tham E.B., Martin A.A., Beare T.H., and Jureidini K.F. Haemolytic-uraemic syndrome outbreak caused by Escherichia coli O111:H: Clinical outcomes. Med J Aust 168 (1998) 552-555
18. Jones C.A., Francis M.E., Eberhardt M.S., et al. Microalbuminuria in the US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 39 (2002) 445-459
19. Garg A.X., Clark W.F., Salvadori M., et al. Microalbuminuria three years after recovery from Escherichia coli O157 hemolytic uremic syndrome due to municipal water contamination. Kidney Int 67 (2005) 1476-1482
20. Schwartz G.J., Haycock G.B., Edelmann Jr. C.M., and Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58 (1976) 259-263
21. Garg A.X., Macnab J., Clark W., et al. Long-term health sequelae following E. coli and Campylobacter contamination of municipal water. Population sampling and assessing non-participation biases. Can J Public Health 96 (2005) 125-130
22. Garg A.X., Moist L., Matsell D., et al. Risk of hypertension and reduced kidney function after acute gastroenteritis from bacteria-contaminated drinking water. CMAJ 173 (2005) 261-268
23. Garg A.X., Marshall J., Salvadori M., et al. A gradient of acute gastroenteritis was characterized, to assess risk of long-term health sequelae after drinking bacterial-contaminated water. J Clin Epidemiol 59 (2006) 421-428
24. Auld H., MacIver D., and Klaassen J. Heavy rainfall and waterborne disease outbreaks: The Walkerton example. J Toxicol Environ Health A 67 (2004) 1879-1887
25. Barratt T.M., McLaine P.N., and Soothill J.F. Albumin excretion as a measure of glomerular dysfunction in children. Arch Dis Child 45 (1970) 496-501
26. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis 39 2 (2002) S1-S266 (suppl 1)
27. Mueller P.W., and Caudill S.P. Urinary albumin excretion in children: Factors related to elevated excretion in the United States population. Ren Fail 21 (1999) 293-302
28. Filler G., Foster J., Acker A., Lepage N., Akbari A., and Ehrich J.H. The Cockcroft-Gault formula should not be used in children. Kidney Int 67 (2005) 2321-2324
29. Filler G., and Lepage N. Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula?. Pediatr Nephrol 18 (2003) 981-985
30. Bokenkamp A., Domanetzki M., Zinck R., Schumann G., Byrd D., and Brodehl J. Cystatin C-A new marker of glomerular filtration rate in children independent of age and height. Pediatrics 101 (1998) 875-881
31. Roos J.F., Doust J., Tett S.E., and Kirkpatrick C.M. Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children-A meta-analysis. Clin Biochem 40 (2007) 383-391
32. Dharnidharka V.R., Kwon C., and Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis. Am J Kidney Dis 40 (2002) 221-226
33. Department of Health and Human Services. A SAS program for the CDC growth charts. www cdc gov/nccdphp/dnpa/growthcharts/resources/sas.htm Accessed December 17, 2007
34. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114 (2004) 555-576
35. Ribeiro M.A. Levels of C-reactive protein in serum samples from healthy children and adults in Sao Paulo, Brazil. Braz J Med Biol Res 30 (1997) 1055-1059
36. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 75 (1988) 800-802
37. Brenner B.M., Lawler E.V., and Mackenzie H.S. The hyperfiltration theory: A paradigm shift in nephrology. Kidney Int 49 (1996) 1774-1777
38. de Jong M., and Monnens L. Haemolytic-uraemic syndrome: A 10-year follow-up study of 73 patients. Nephrol Dial Transplant 3 (1988) 379-382
39. Gillor A., Bulla M., Roth B., et al. Plasmapheresis as a therapeutic measure in hemolytic-uremic syndrome in children. Klin Wochenschr 61 (1983) 363-367
40. Janssen F., Potvliege P.R., Vainsel M., and Vis H.L. [Short- and long-term prognosis of the hemolytic-uremic syndrome]. Arch Fr Pediatr 31 (1974) 59-69
41. Monnens L., van Collenburg J., de Jong M., Zoethout H., and van Wieringen P. Treatment of the hemolytic-uremic syndrome. Comparison of the results of heparin treatment with the results of streptokinase treatment. Helv Paediatr Acta 33 (1978) 321-328
42. Tonshoff B., Sammet A., Sanden I., Mehls O., Waldherr R., and Scharer K. Outcome and prognostic determinants in the hemolytic uremic syndrome of children. Nephron 68 (1994) 63-70
43. Wende-Fischer R., Hoyer P.F., Offner G., and Brodehl J. Hamolytisch-uramisches Syndrom im Kindesalter [Haemolytic uraemic syndrome. Clinical features, treatment and prognostic indicators.]. Monatsschr Kinderheilkd 144 (1996) 526-533
44. Jones C.A., McQuillan G.M., Kusek J.W., et al. Serum creatinine levels in the US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 32 (1998) 992-999